Evidence map›Paper›PMID 41493809›Full record

ArticleKidney3602026

Senolytic Changes in Murine Arteriovenous Fistulas with CKD.

Jamie Kane, Sreenivasulu Kilari, Alaura Lemieux, Prabh G Singh, Nathaniel Anderson, Dominik Saul, Tamar Tchkonia, James L Kirkland, Sanjay Misra

Abstract read
In one paragraph

Article in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jamie KaneVascular and Interventional Radiology Translational Research Lab, Mayo Clinic, Rochester, Minnesota.ORCID 0009-0005-0129-0075
Sreenivasulu KilariVascular and Interventional Radiology Translational Research Lab, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-9149-7360
Alaura LemieuxVascular and Interventional Radiology Translational Research Lab, Mayo Clinic, Rochester, Minnesota.ORCID 0009-0004-6192-0983
Prabh G SinghVascular and Interventional Radiology Translational Research Lab, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-4755-1056
Nathaniel AndersonVascular and Interventional Radiology Translational Research Lab, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-6545-4693
Dominik SaulKogod Center on Aging and Division of Endocrinology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-0673-3710
Tamar TchkoniaCedars-Sinai Medical Center, Los Angeles, California.ORCID 0000-0003-4623-7145
James L KirklandCedars-Sinai Medical Center, Los Angeles, California.ORCID 0000-0003-1676-4905
Sanjay MisraVascular and Interventional Radiology Translational Research Lab, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-5662-796

Funding

The Role of Hypoxia In Venous Neointimal Hyperplasia In Hemodialysis GraftsR01HL098967 · NHLBI · MAYO CLINIC ROCHESTER · PI Sanjay Misra · 2010 to 2026
$10.4M
Monocyte chemoattractant Proteins and Vascular InjuryR01DK135407 · NIDDK · MAYO CLINIC ROCHESTER · PI Sanjay Misra · 2023 to 2026
$2.8M
National Heart and Lung Institute HL098967NHLBI NIH HHS R01 HL098967NIDDK NIH HHS DK135407NIDDK NIH HHS DK139817NIDDK NIH HHS DK165407NIDDK NIH HHS R01 DK135407
6 · The paper itself

Abstract

key pointsThis study reveals the temporal development and progression of senescence in an arteriovenous fistula of uremic mice. Senescent genes including p21 increased 7 days after arteriovenous fistula placement, and p16 and phosphorylated p53 cells accumulate between days 14 and 28. Transcriptomic analyses confirm established genes in arteriovenous fistula failure and suggest a collection of novel genes of interest.

backgroundHemodialysis therapy for ESKD requires suitable vascular access, most commonly the arteriovenous fistula (AVF). Forty percent of AVFs fail within 1 year, leading to morbidity and care costs. Failure mechanisms remain unclear, and current therapies are inadequate. Cellular senescence may be critical in AVF failure, and ESKD itself may accelerate senescence and subsequent vascular dysfunction. Senescence follows AVF placement in rodents with normal kidney function, but the temporal and spatial features in uremic conditions are unknown. This study aimed to characterize AVF changes in uremic mice over time and versus control vessels.

methodsSix- to eight-week-old male C57BL6/J mice underwent five/six nephrectomy. Twenty-eight days later, an AVF was created by cuff anastomosis (right carotid artery to the right jugular vein). Transcriptomic analysis was performed 7 days post-AVF, and further samples were collected at 14 and 28 days post-AVF creation for histologic assessment.

resultsAVF outflow vein morphometry showed reduced neointimal cell density. Whole transcriptomic analysis of outflow versus control veins at 7 days post-AVF placement revealed 1187 upregulated and 3256 downregulated genes. Differentially expressed genes were significantly enriched in two established senescence-related gene sets, SenMayo (a curated panel of approximately 125 genes validated across species to capture senescence and associated proteins) and SenSig (a broader panel assessed to represent fibrotic and stress-induced cell response). Histologically, senescence markers p16, p21, and phospho53 increased between days 14 and 28. Genes common to our dataset, SenMayo, and SenSig were validated with quantitative reverse transcription PCR.

conclusionsThese data support established markers of AVF failure, such as matrix-metalloproteinases and monocyte chemokines, and identify potential novel modulators of AVF survival that may inform senolytic strategies to improve patency. In summary, this study reveals for the first time the chronologic progression of vascular senescence in the AVF of uremic mice.

Indexed as

Arteriovenous Shunt, SurgicalCellular SenescenceRenal DialysisRenal Insufficiency, ChronicUremiaAnimalsCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21Disease Models, AnimalGene Expression ProfilingJugular VeinsMaleMiceMice, Inbred C57BLTumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21Tumor Suppressor Protein p53arteriovenous fistulabasic sciencevascular accessvascular disease

Identifiers

PMID41493809
PMCPMC13450964

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.